Flipping the switch: Integrin switching provides metastatic competence

Science Signaling

Volumn 7, Issue 318, 2014, Pages

  Madamanchi, Aasakiran ^a   Zijlstra, Andries ^a   Zutter, Mary M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; BETA1 INTEGRIN; HETERODIMER; INTEGRIN; LIGAND; MYC PROTEIN; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; CANCER CELL; CANCER PATIENT; GENE EXPRESSION; GENE SWITCHING; HUMAN; HUMAN CELL; LIGAND BINDING; MEDIATOR; METASTASIS; MOLECULAR BIOLOGY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; EXTRACELLULAR MATRIX; LUNG TUMOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SECONDARY;

ANIMALS; ANTIGENS, CD29; EXTRACELLULAR MATRIX; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84897145001     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005236     Document Type: Short Survey

References (12)

1. J. S. Desgrosellier, D. A. Cheresh, Integrins in cancer: Biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9-22 (2010).
2. T. D. Palmer, C. H. Martínez, C. Vasquez, K. E. Hebron, C. Jones-Paris, S. A. Arnold, S. M. Chan, V. Chalasani, J. A. Gomez-Lemus, A. K. Williams, J. L. Chin, G. A. Giannico, T. Ketova, J. D. Lewis, A. Zijlstra, Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression. Cancer Res. 74, 173-187 (2014).
3. D. E. White, N. A. Kurpios, D. Zuo, J. A. Hassell, S. Blaess, U. Mueller, W. J. Muller, Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6, 159-170 (2004).
4. 1 integrin is a metastasis suppressor in mouse models and human cancer. J. Clin. Invest. 121, 226-237 (2011).
5. 1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer. Sci. Signal. 7, ra15 (2014).
6. J. G. Parvani, A. J. Galliher-Beckley, B. J. Schiemann, W. P. Schiemann, Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β. Mol. Biol. Cell 24, 3449-3459 (2013).
7. H. Liu, D. C. Radisky, D. Yang, R. Xu, E. S. Radisky, M. J. Bissell, J. M. Bishop, MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat. Cell Biol. 14, 567-574 (2012).
8. J. L. Leight, M. A. Wozniak, S. Chen, M. L. Lynch, C. S. Chen, Matrix rigidity regulates a switch between TGF-β1-induced apoptosis and epithelial-mesenchymal transition. Mol. Biol. Cell 23, 781-791 (2012).
9. B. D. Lehmann, J. A. Bauer, X. Chen, M. E. Sanders, A. B. Chakravarthy, Y. Shyr, J. A. Pietenpol, Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750-2767 (2011).
10. P. A. Muller, P. T. Caswell, B. Doyle, M. P. Iwanicki, E. H. Tan, S. Karim, N. Lukashchuk, D. A. Gillespie, R. L. Ludwig, P. Gosselin, A. Cromer, J. S. Brugge, O. J. Sansom, J. C. Norman, K. H. Vousden, Mutant p53 drives invasion by promoting integrin recycling. Cell 139, 1327-1341 (2009).
11. A. Arjonen, R. Kaukonen, E. Mattila, P. Rouhi, G. Högnäs, H. Sihto, B. W. Miller, J. P. Morton, E. Bucher, P. Taimen, R. Virtakoivu, Y. Cao, O. J. Sansom, H. Joensuu, J. Ivaska, Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis. J. Clin. Invest. 124, 1069-1082 (2014).
12. M. Adorno, M. Cordenonsi, M. Montagner, S. Dupont, C. Wong, B. Hann, A. Solari, S. Bobisse, M. B. Rondina, V. Guzzardo, A. R. Parenti, A. Rosato, S. Bicciato, A. Balmain, S. Piccolo, A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137, 87-98 (2009).